336 related articles for article (PubMed ID: 18834359)
1. Biosimilars: it's not as simple as cost alone.
Roger SD; Goldsmith D
J Clin Pharm Ther; 2008 Oct; 33(5):459-64. PubMed ID: 18834359
[TBL] [Abstract][Full Text] [Related]
2. Follow-on biologics: challenges of the "next generation".
Schellekens H
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv31-36. PubMed ID: 15827057
[TBL] [Abstract][Full Text] [Related]
3. Recommendations regarding technical standards for follow-on biologics: comparability, similarity, interchangeability.
Davis GC; Beals JM; Johnson C; Mayer MH; Meiklejohn BI; Mitlak BH; Roth JL; Towns JK; Veenhuizen M
Curr Med Res Opin; 2009 Jul; 25(7):1655-61. PubMed ID: 19476407
[TBL] [Abstract][Full Text] [Related]
4. Biosimilars: how similar or dissimilar are they?
Roger SD
Nephrology (Carlton); 2006 Aug; 11(4):341-6. PubMed ID: 16889575
[TBL] [Abstract][Full Text] [Related]
5. Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticals.
Blackstone EA; Fuhr JP
Future Med Chem; 2010 Nov; 2(11):1641-9. PubMed ID: 21428836
[TBL] [Abstract][Full Text] [Related]
6. Biosimilar epoetins and other "follow-on" biologics: update on the European experiences.
Jelkmann W
Am J Hematol; 2010 Oct; 85(10):771-80. PubMed ID: 20706990
[TBL] [Abstract][Full Text] [Related]
7. Basic facts about biosimilars.
Nowicki M
Kidney Blood Press Res; 2007; 30(5):267-72. PubMed ID: 17622764
[TBL] [Abstract][Full Text] [Related]
8. [Biosimilars or follow-on biologics in dermatology].
Puig L
Actas Dermosifiliogr; 2010; 101(1):4-6. PubMed ID: 20109387
[No Abstract] [Full Text] [Related]
9. Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the United States.
Hennessy S; Leonard CE; Platt R
Clin Pharmacol Ther; 2010 Feb; 87(2):157-9. PubMed ID: 20107450
[TBL] [Abstract][Full Text] [Related]
10. European regulatory guidelines for biosimilars.
Wiecek A; Mikhail A
Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v17-20. PubMed ID: 16959790
[TBL] [Abstract][Full Text] [Related]
11. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars.
Gitter DM
Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759
[No Abstract] [Full Text] [Related]
12. Biosimilars: current status and future directions.
Roger SD
Expert Opin Biol Ther; 2010 Jul; 10(7):1011-8. PubMed ID: 20384525
[TBL] [Abstract][Full Text] [Related]
13. Assessing the bioequivalence of biosimilars The Retacrit case.
Schellekens H
Drug Discov Today; 2009 May; 14(9-10):495-9. PubMed ID: 19429509
[TBL] [Abstract][Full Text] [Related]
14. Biosimilars: opportunity or cause for concern?
Roger SD; Mikhail A
J Pharm Pharm Sci; 2007; 10(3):405-10. PubMed ID: 17727803
[TBL] [Abstract][Full Text] [Related]
15. Comparative testing and pharmacovigilance of biosimilars.
Locatelli F; Roger S
Nephrol Dial Transplant; 2006 Oct; 21 Suppl 5():v13-6. PubMed ID: 16959789
[TBL] [Abstract][Full Text] [Related]
16. [The industry recommends increased use. Biosimilars are like generics, but still not].
Bergström R; Nyblom K
Lakartidningen; 2010 Oct 20-26; 107(42):2584-5. PubMed ID: 21137555
[No Abstract] [Full Text] [Related]
17. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting.
Lamarque V; Merle L; Demarez JP;
Therapie; 2008; 63(4):301-9. PubMed ID: 18937910
[TBL] [Abstract][Full Text] [Related]
18. Equivocal role of micelles in Eprex adverse events.
Smiell JM
Nat Biotechnol; 2003 Nov; 21(11):1265; author reply 1266. PubMed ID: 14595347
[No Abstract] [Full Text] [Related]
19. Equivocal role of micelles in Eprex adverse events.
Schellekens H; Crommelin DJ
Nat Biotechnol; 2003 Nov; 21(11):1265; author reply 1266. PubMed ID: 14595346
[No Abstract] [Full Text] [Related]
20. The challenge of follow-on biologics for treatment of multiple sclerosis.
Reingold SC; Steiner JP; Polman CH; Cohen JA; Freedman MS; Kappos L; Thompson AJ; Wolinsky JS
Neurology; 2009 Aug; 73(7):552-9. PubMed ID: 19687456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
